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Synovial Phagocytic Lining Cells: 
Focus of Inflammation?
Rheumatoid arthritis (RA) is a systemic inflamma­
tory disease predominantly localized in the synovial 
joints. The reason why synovial joints are the main 
localization of the inflammatory process is an in­
triguing and as yet unanswered question. In this 
paper we focus on the synovial lining layer, a thin 
layer of cells which covers the surface of the syn­
ovial tissue, as a possible starting point of arthritis.
The synovium consists of a sublining layer cov­
ered by the lining layer. The sublining layer con­
tains loose connective tissues in which fenestrated 
bloodvessels are embedded. The one to two cell 
thick, lining layer is composed of two distinct cell 
populations (1). The resident type B cells, having 
characteristics similar to fibroblasts and type A cells 
which are macrophage-like (1). They are proba­
bly descendants from peripheral monocytes (2) and 
are constantly replaced via the circulation. Un­
der the influence of local factors like granulocyte- 
macrophage stimulating factor (GM-CSF), mono­
cytes may change in more resident macrophages 
(3) which have different surface markers.
Prior to the onset of arthritis, phagocytic lining 
cells become activated by as yet unknown mecha­
nisms. Activation of these cells and other synovial 
cells may direct the influx of inflammatory cells like 
polymorphonuclear cells (PMN), monocytes and T 
cells into the joint tissues, characteristic for arthritis 
development. In RA, a striking early observation is 
that increased numbers of cells occupy the synovial 
lining layer (4). This thickening of the lining layer 
is mainly due to accretion of macrophages from 
the periphery, which accumulate around this layer. 
The contribution of type A cells in the human lin­
ing layer increases from approximately 20-30% in 
health to 80-100% in RA (5). Phagocytic lining 
cells release many pro-inflammatory factors . Im- 
munolocalization studies have shown that many of
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these pro-inflammatory mediators are expressed in 
the lining layer like IL-1 a (6), TNFa(7), TGF/3(8), 
IL-6(9), IL-8 (10) and GM-CSF (11). The above 
observations suggest that both in RA and in ex­
perimental models, phagocytic lining cells may be 
involved in attraction of inflammatory cells dur­
ing onset of arthritis and probably also in arresting 
these cells within the synovium during the chronic 
phase. To get further insight in this matter, we 
carried out several studies in experimental arthritis 
models.
Selective Depletion of Phagocytic 
Lining Cells from Murine Knee Joints
There are several ways to study the possible role 
of phagocytic lining cells in experimental arthri­
tis. One approach may be the isolation of synovial 
cells from pre-inflammatory synovia and transfer 
of these cells to control animals. Recent studies 
by Ramoz-Ruis showed that macrophage-like syn­
ovial lining cells isolated from pre-inflammatory 
synovium from rats with experimental adjuvant 
arthritis were able to transfer arthritis if these cells 
were injected into control rats (12). Another ap­
proach which was chosen by us, is selective de­
pletion of phagocytic cells prior to arthritis induc­
tion or during established arthritis. Several meth­
ods to eliminate synovial lining cells have been 
described. Local deposition of osmium tetroxide 
(13) or radioisotopes (14) in knee joints indeed 
showed downregulation of the lining cell function. 
However, the disadvantages of these methods are 
that they are nonselective and often cause side ef­
fects on other joint tissues (15). In our studies we 
used liposomes which contain the drug Clodronate 
(dichloromethylene bisphosphonate: CL2MDP: gift 
from Boehringer Mannheim). This drug belongs 
to a class of synthetic compounds structurally re­
lated to pyrophosphate, an endogenous regulator of 
calcium metabolism. We made use of the phago­
cytic properties of the macrophage which prefer­
entially absorbs the relatively large (1 /¿M) multi-
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lamellar liposomes. Once inside the cell, the lipid 
bilayer is disrupted by lysosomal enzymes, the drug 
sets free and induces cell death probably by its 
chelating activity (16). Most likely not intracel­
lular Csr+ but Fe2+ arrestment leads to macrophage 
elimination (17). In this way macrophages can be 
eliminated from various compartments like spleen 
(18), liver (19), lung (20) and lymph nodes (21) 
if given via the appropriate routes. We injected 
clodronate-liposomes directly into the joint com-* 
partment. A single injection of six fû  liposomes 
containing 75 f ig  clodronate into control murine 
knee joints resulted in selective depletion of phago­
cytic lining cells. Optimal depletion was found be­
tween 6 and 11 days after liposome injection but 
even after 30 days the lining has not recovered fully 
(22). No deleterious effects were found on other 
joint tissues at the time that full depletion of phago­
cytic lining cells in the knee joint was observed. 
The free drug, 14C labeled clodronate is not taken 
up by cells (23) and had no effect on macrophages. 
Taken together this simple in vivo macrophage “sui­
cide” technique is selective and shows no deleteri­
ous effects on other joint tissues.
Involvement of Phagocytic Lining Cells 
in Onset of Expermental Arthritis
To examine the role of phagocytic lining cells in 
the onset of arthritis, we studied both a locally and 
a systemically induced arthritis. The former was 
induced by cationic immune complexes (ICA). We 
inject a cationic antigen directly into knee joints of 
mice which previously were given antibodies di­
rected against the antigen. A severe arthritis then 
developes characterized by influx of mainly PMNs 
into the synovial layer (24). Clodronate-liposomes 
were injected one week prior to arthritis induc­
tion. At the time-point of arthritis induction, the 
lining layer was totally stripped. Arthritis induc­
tion in lining cell depleted knee joints caused a sig­
nificantly reduced influx of PMN (25) (Figure 1). 
In these experiments, synovitis was scored from 
haematoxylin/eosin stained total knee joint sec­
tions. These data suggest that the phagocytic lining 
cell is essential in the induction of arthritis in this 
model.
In the ICA, the arthritis trigger first meets the 
lining layer. Cationic immune complexes stick pre­
dominantly to the lining layer which subsequently 
becomes activated. These immune complexes have
two important properties. First, cationicity (26,27) 
and size (28) of the immune complexes lead to
prolonged persistence in the joint structures. Sec­
ondly, cationic immune complexes induce at least 
two chemotactic mediators involved in cell influx 
within this model, i.e. C5a and IL-1. The latter 
probably acts by inducing IL-8-like chemokines. 
Production of IL-1 and the chemotactic activity in 
lining depleted arthritic knee joints were shown to 
be both significantly decreased (25). Lowering of 
IL-1 production as a reason for decreased PMN in­
flux was further substantiated by studies showing 
that neutralization of IL-1 effects by anti-IL-1 an­
tibodies (24) or IL-1 receptor antagonist (29) also 
decreased PMN influx significantly.
Since lining depletion may only act in the induc­
tion phase of a locally induced arthrititis in which 
the trigger meets the lining directly, we further 
studied the effect of phagocytic lining depletion on 
the onset and expression of a systemically induced 
arthritis. As a model we used collagen type II in­
duced arthritis (CIA). DBA/1 lac j mice were im­
munized with bovine collagen type II in Complete 
Freunds Adjuvant subcutaneously into the base of 
the tail. Three weeks later, mice were boosted with 
100 f-ig collagen type II intravenously. One week 
thereafter bacterial lipopolysacccaride (LPS) was 
given intrapedtoneally to synchronize and elevate 
the expression of arthritis within the knee joint (30). 
When no LPS is given, expression of arthritis in the 
knee joint is usually low and variable. Four days af­
ter LPS injection a severe arthritis developed char­
acterized by influx of PMN and monocytes mainly 
into the synovial layer. In recent studies we in­
jected clodronate-liposomes locally in knee joints 
at day 9 before the expected expression of arthri­
tis in the knee joint, leading to absence of lining 
layer at the onset of arthritis. In these experiments 
we could show that two days after start of arthritis, 
cell influx into the synovial layer of lining depleted 
knee joints was significantly decreased (Figure 1). 
This indicates that phagocytic lining cells are im­
portant in the local expression of the systemically 
induced CIA. Like in the immune complex medi­
ated model, IL-1 seems the dominant cytokine in­
volved in the onset of CIA. Neutralization of IL-1 
effects by anti-IL-1 antibodies (31) or IL-1 receptor 
antagonist (data not shown) fully blocked the influx 
of cells into the joint cavity. We are currently de­
termining IL-1 levels and chemotactic activity in 
lining depleted knee joints in CIA.
In CIA both immune complexes and T cells 
have been described to be important in the onset of 
arthritis. Like in immune complex mediated arthri­
tis, collagen type Il-immune complexes may trigger 
the lining first. If the T cell is the first drive, this
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cell may be immobilized in the sublining layer. Ac­
tivated T cells which art mostly found adjacent to 
macrophages (32), may release cytokines which ac­
tivate the lining from a distance. The results from 
lining depletion in both experimental models sug­
gest that the larger part of the chemotactic activ­
ity is generated by phagocytic lining cells. Earlier 
studies revealed that local injection of recombinant 
murine IL-1 in murine knee joints induced massive 
influx of PMN (33). In lining depleted knee joint, 
IL-1 was however not able to induce influx of cells 
(25), again indicating that PMN chemotactic factors 
are primairly formed by the lining layer. It there­
fore appears that IL-1 and probably also TNF, the 
major products of activated macrophages, might be 
highly inflammatory by stimulating the release of
chemokines by phagocytic lining cells. They pro­
duce both a and ß  chemokines. The a  chemokines 
like GROa and IL-8 attract PMN, although GROa 
is 10 times more potent (34). In RA synovial fluid 
chemotactic activity for PMN was inhibited 40 ± 
5% upon incubation with neutralizing polyclonal 
antibody to IL-8 (35). Furthermore phagocytic lin­
ing cells release ß  monokines like chemotactic and 
activating factor (MCAF) or MCP-1 which predom­
inantly attracts monocytes both in vitro and in vivo 
(36). MCP-1 also attracts B cells, cytotoxic T cells 
and CD4+ T cells. Macrophages from RA syn­
ovium constitutively express MCP-1 mRNA and 
protein (37).
So in summary, the phagocytic lining layer 
seems involved in the onset and expression of
4
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Figure I: Effect of elimination of phagocytic lining cells from the murine knee joint on the onset of a local (immune 
complex mediated arthritis: ICA) and a systemically induced (collagen type II induced arthritis: CIA) arthritis. Note
the significantly reduced synovitis in the lining depleted clodronate-liposome treated arthritic knee joints. Synovitis 
was scored in an arbitrary way (0 = no; 1 = minor; 2 = moderate; 3 = marked).
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both locally and systemically induced experimental 
arthritis. The next question was whether the phago­
cytic lining layer is also involved in the perpetua­
tion of synovitis in an established arthritis. If so, 
local injection of clodronate-liposomes into large 
inflamed RA joints might be a possible treatment.
Involvement of Phagocytic 
Lining Cells in The Propagation 
of Established Arthritis
To investigate this, we used the antigen (mBSA) 
induced arthritis model (AIA). AIA is induced by 
injecting a cationic antigen into knee joints of mice 
which previously are immunized with the antigen in 
Complete Freunds Adjuvant. A severe acute arthri­
tis is followed by a T cell driven chronic phase (27). 
The chronic phase is characterized by a synovi­
tis which consists of monocytes and T cells which 
have been infiltrated from the blood compartment 
(38). The smouldering synovitis in the knee joint 
can be reactivated by giving the antigen systemi­
cally (39,40). In the chronic phase of this arthritis, 
the activated lining cells which release chemotac­
tic factors may be responsible for the propagation 
of the synovitis. To investigate this we injected 
clodronate-liposomes both in the acute and chronic 
phase of antigen-induced inflamed knee joints. As 
controls, PBS or PBS-containing liposomes were 
given. If clodronate-liposomes were given shortly 
(6 hrs, 1 day and 3 days) after arthritis onset, no 
effect was found on synovitis (41). The reason for 
this was that liposomes are rapidly degraded in an 
PMN rich inflammatory exudate and fail to reach 
the lining layer (41). However when clodronate- 
liposomes were given in the more chronic phase of 
arthritis (7 days after arthritis onset), we observed 
a significant downregulation of synovitis at day 21 
after arthritis onset (Figure 2). Since most PMNs 
have disappeared from the joint cavity at this time 
point, the injected liposomes can easily reach the 
lining layer. Clodronate-liposomes stained by a flu­
orescent dye were shown to penetrate deeply into 
the thickened layer. By eliminating part of the acti­
vated phagocytic synovial cells in the lining layer, 
the synovitis may come to rest. In our hands a sin­
gle injection of clodronate-liposomes was sufficient 
to eliminate the synovitis and no relapse was found 
three or four weeks after liposome treatment (41).
Which mechanisms are involved in persistence 
of the synovitis are still unknown. The cationic 
proteins which are used in this model are able to
persist in collagenous and cartilagenous joint tis­
sues. Cationic antigens disappear from the syn­
ovium much faster than from cartilagenous layers. 
The cartilage matrix forms a depot of negatively 
charged proteoglycans, in which large amounts of 
antigen can persist for prolonged periods forming 
an antigen reservoir (42,43). Continuous release 
of small amounts of the antigen from the cartilage 
may keep the phagocytic lining cells in a perma­
nent state of activation. As cationic antigens are 
potent inducers of IL-1, they may trigger indirectly 
the generation of chemokines like IL-8 or MCAF 
from the lining layer thus sustaining inflammation. 
That IL-1 might be involved in sustaining inflam­
mation in antigen-induced arthritis was substanti­
ated by the observation that neutralization of IL-1 
by anti-IL-1 antibodies decreased the influx of in­
flammatory cells in later phases of antigen-induced
arthritis (44).
Phagocytic Lining Cells Are Involved in 
Exacerbation of Smouldering Arthritis
Apart from sustaining synovitis, the phagocytic lin­
ing cells may also be involved in flares of inflam­
mation which can be elicited by giving the anti­
gen either orally (40) or intravenously (41). Small 
amounts of the antigen reaching the hyperreactive 
joint can elicit a renewed flare. In the flare reaction, 
T cells and antigen presenting cells play a dominant 
role. The flare could be blocked by giving either 
anti lymphocyte serum (45) or anti-la antibodies 
(46). Within a couple of hours after induction of 
the flare, large amounts of IL-1 and IL-6 are gener­
ated. Numerous cells, mainly PMNs, infiltrate the 
synovial layer. Injecting small amounts of mBSA 
into lining depleted joints showed reduced cell in­
flux (50%) (Figure 2). This was again correlated 
to reduced levels of IL-1 (data not shown).
Apart from releasing pro-inflammatory 
molecules, macrophages also release anti­
inflammatory molecules. For instance inhibitors of 
pro-inflammatory cytokines like IL-1 receptor an­
tagonist (IL-lra) and anti-inflammatory cytokines 
like IL-4 and IL-10. This negative feedback 
may thus disappear after lining depletion. Many 
cells producing anti-inflammatory factors seem 
however to be resided in the sublining layer which 
is not reached by the liposomes. IL-lra which 
blocks competitively the binding of IL-1 and to 
their receptors (47), was primarily located in the 
perivascular regions enriched for macrophages in 
the sublining layer in 11 of 12 rheumatoid synovial 
tissues examined (48). T helper 2 cells, producers
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of IL-4 and IL-10 also reside in the sublining 
layer and are closely associated with activated 
macrophages (49). Thus removal of the superficial 
lining cells at least leaves a substantial number of 
cells, located in the sublining tissue, generating 
anti-inflammatory factors.
In above experimental studies a clear amelio­
rating effect of lining depletion either on onset or 
persistence of inflammation in the inflamed knee 
joint was found. Whether macrophage depletion 
has benificial effects of inflammation in the hu­
man joint has to be studied. Recent prospective 
studies in the RA joint, have examined the impact 
of synovial lining cellularity on the disease course 
in RA. In milder forms of RA there was less in­
tense accumulation of cells in the synovial lining
and little clinical deterioration over a 3-year period 
of follow up (49). In a second study of radiological 
progression in RA the number of macrophages but 
not of lymphocyte populations infiltrating the syn­
ovial membrane correlated with deterioration over 
a 1-year period of follow-up (50).
These studies indicate that eliminating activated 
phagocytic synovial cells by local injection of 
clodronate-liposomes might be a promising tool 
to downregulate inflammation.
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